Skip to content

Clinical trials

Phase 1 Mood Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 1 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20151
20172
20182
20192
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Luye Pharma Group Ltd.5
Brigham and Women's Hospital1
Laureate Institute for Brain Research, Inc.1
Mary Fristad1
Minneapolis Veterans Affairs Medical Center1
National Institute of Mental Health (NIMH)1
University of Minnesota1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders12
Mental Disorders8
Major Depressive Disorder7
Depressive Disorder5
Anxiety Disorders3
Stress Disorders, Post-Traumatic3
Depressive Disorder, Treatment-Resistant2
Psychotic Disorders2
Schizophrenia2
Stress Disorders, Traumatic2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.